Stay updated with breaking news from Cov Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Progressing broad vaccine development program in collaboration with GSK, with second-generation candidates in Phase 1 clinical trials for COVID-19 and influenzaCureVac eligible to a €10 million milestone
Investegate announcements from CureVac, CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update
25.05.2022 - Issuer: CureVac / Key word(s): Quarter Results CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update 25.05.2022 / 13:05 The issuer is solely responsible for the content of this announcement. CureVac ...
Issuer: CureVac / Key word(s): Quarter Results25.05.2022 / 13:05 The issuer is solely responsible for the content of this announcement.CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update Progressing broad vaccine development program in collaboration with GSK, with second-g...
DGAP-News: CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update